「简报」卡耐基梅隆大学表彰 11 名杰出校友;ARPA-H 快速开发新的癌症植入技术
10 月 2 日,卡耐基梅隆大学公布了 2023 年校友奖获奖名单。从揭开人类基因组最小组成部分的奥秘,到在最大的屏幕上激励观众,这 11 名校友正在开拓道路,取得个人和职业上的成功,同时回馈了那些追随他们脚步的人。
“对世界产生积极影响的愿望是卡耐基梅隆大学的核心,” Brit McCandless Farmer 说道,他是卡耐基梅隆大学的受托人,兼卡耐基梅隆大学校友会董事会主席,也是 Dietrich 人文与社会科学学院的校友。“今年的校友奖获奖者正是通过他们的专业、职业和为他人服务做到了这一点。这些 Tartans 让我们所有人感到自豪,我很高兴与卡耐基梅隆大学社区分享他们的成就。”
了解更多:
https://www.cmu.edu/engage/about-us/news/alumni/alumniawardshonorees2023.html
Today, Carnegie Mellon University announced the 2023 Alumni Award honorees. From uncovering mysteries within the smallest part of the human genome to delighting audiences on the biggest screens, these 11 alumni are blazing trails and achieving personal and professional successes — all while giving back to those who follow in their footsteps.
“The desire to make a difference and have a positive impact on the world is at the center of the CMU experience,” said Brit McCandless Farmer, CMU trustee, CMU alumni Association Board president and a Dietrich College of Humanities and Social Sciences alumna. “This year’s Alumni Award honorees are doing just that through their professions and vocations and in their service to others. These Tartans make us all proud, and I am thrilled to share their accomplishments with the CMU community.”
Learn More:
https://www.cmu.edu/engage/about-us/news/alumni/alumniawardshonorees2023.html
ARPA-H 快速开发新的癌症植入技术
卫生高级研究计划局(ARPA-H)已拨款 4500 万美元用于快速开发感知与响应植入技术,而植入技术将有可能将美国癌症相关的死亡人数减少 50% 以上。
本周宣布,该奖项将颁发给包括卡耐基梅隆大学在内的多机构研究团队,该团队将快速开发和测试一种新的癌症治疗方法,旨在显著改善对于卵巢癌、胰腺癌和其他疑难病症患者的免疫治疗效果。
了解更多:
https://www.cmu.edu/news/stories/archives/2023/september/arpa-h-fast-tracks-development-of-new-cancer-implant-tech
The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more than 50%.
Announced this week, the award to a multi-institutional team of researchers, including Carnegie Mellon University, will fast-track development and testing of a new approach to cancer treatment that aims to dramatically improve immunotherapy outcomes for patients with ovarian, pancreatic and other difficult-to-treat cancers.
Learn More:
https://www.cmu.edu/news/stories/archives/2023/september/arpa-h-fast-tracks-development-of-new-cancer-implant-tech
▽
这里是卡耐基梅隆大学
中国校友会
长按扫码关注我们
关键词
卡耐基梅隆大学
www.cmu.edu
了解更多
团队
是卡耐基梅隆大学
最新评论
推荐文章
作者最新文章
你可能感兴趣的文章
Copyright Disclaimer: The copyright of contents (including texts, images, videos and audios) posted above belong to the User who shared or the third-party website which the User shared from. If you found your copyright have been infringed, please send a DMCA takedown notice to [email protected]. For more detail of the source, please click on the button "Read Original Post" below. For other communications, please send to [email protected].
版权声明:以上内容为用户推荐收藏至CareerEngine平台,其内容(含文字、图片、视频、音频等)及知识版权均属用户或用户转发自的第三方网站,如涉嫌侵权,请通知[email protected]进行信息删除。如需查看信息来源,请点击“查看原文”。如需洽谈其它事宜,请联系[email protected]。
版权声明:以上内容为用户推荐收藏至CareerEngine平台,其内容(含文字、图片、视频、音频等)及知识版权均属用户或用户转发自的第三方网站,如涉嫌侵权,请通知[email protected]进行信息删除。如需查看信息来源,请点击“查看原文”。如需洽谈其它事宜,请联系[email protected]。